T. Rowe Price Associates’s Protara Therapeutics TARA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50K | Buy |
+16,353
| New | +$50K | ﹤0.01% | 3007 |
|
|
2021
Q2 | – | Sell |
-319,326
| Closed | -$5.03M | – | 2945 |
|
|
2021
Q1 | $5.03M | Sell |
319,326
-114,272
| -26% | -$1.8M | ﹤0.01% | 1464 |
|
|
2020
Q4 | $10.5M | Sell |
433,598
-14,495
| -3% | -$351K | ﹤0.01% | 1341 |
|
|
2020
Q3 | $7.54M | Buy |
+448,093
| New | +$7.54M | ﹤0.01% | 1354 |
|